-61.55 (-3.68%) Sun Pharmaceutical Industries is planning to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion. The field force expansion done in FY21 has met with good success and considering the current market conditions.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.